MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

MEDNAX Company Profile (NYSE:MD)

Consensus Ratings for MEDNAX (NYSE:MD) (?)
Ratings Breakdown: 3 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.73)
Consensus Price Target: $79.13 (10.73% upside)

Analysts' Ratings History for MEDNAX (NYSE:MD)
Show:
DateFirmActionRatingPrice TargetActions
6/8/2016Jefferies GroupReiterated RatingBuy$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Robert W. BairdReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2016MizuhoBoost Price TargetBuy$75.00 -> $79.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016Piper JaffrayReiterated RatingOverweight$76.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/8/2016Stifel NicolausLower Price TargetBuy$81.00 -> $76.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/7/2016SusquehannaDowngradePositive -> Neutral$94.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2015StephensReiterated RatingEqual Weight$77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015JPMorgan Chase & Co.Lower Price Target$94.00 -> $85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2015Citigroup Inc.Initiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/20/2015William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015Dougherty & CoBoost Price TargetBuy$88.00 -> $90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015Deutsche BankReiterated RatingBuy$77.00 -> $79.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015Raymond JamesBoost Price TargetOutperform$78.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/16/2014SunTrustInitiated CoverageNeutral$62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for MEDNAX (NYSE:MD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
4/28/2016Q116$0.86$0.87$741.49 million$752.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2016Q415$1.10$1.13$748.02 million$742.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q315$0.97$1.10$730.63 million$722.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q215$0.88$0.90$677.02 million$676.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q115$0.71$0.72$641.24 million$639.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2015Q414$0.86$0.89$637.90 million$651.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314$0.85$0.86$619.61 million$627.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q214$0.78$0.79$603.00 million$595.54 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q114$0.63$0.63$574.80 million$566.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2014Q4$0.75$0.20$555.30 million$567.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/31/2013Q313$1.48$1.52$556.63 million$555.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2013Q2 2013$1.36$1.37$533.39 million$529.18 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q1 2013$1.09$1.10$504.24 million$502.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2013Q4 2012$1.30$1.32$473.70 million$471.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312$1.28$1.32$470.60 million$473.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2012$1.19$1.22ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2012$1.00$0.98ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/2/2012$1.19$1.19ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011$1.18$1.19ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2011$1.15$1.15ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011$0.91$0.94ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2011$1.12$1.12ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for MEDNAX (NYSE:MD)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161$1.08$1.08$1.08
(Data provided by Zacks Investment Research)
Dividend History for MEDNAX (NYSE:MD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for MEDNAX (NYSE:MD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/13/2016Dominic J AndreanoSVPSell3,922$68.80$269,833.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2016Md Carlo A WaldemarDirectorSell5,334$70.50$376,047.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2016Karl B WagnerInsiderSell27,482$68.45$1,881,142.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016Joseph M CalabroCOOSell28,347$67.78$1,921,359.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016Michael D StanleyInsiderSell14,778$67.78$1,001,652.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Dominic J AndreanoSVPSell3,000$68.53$205,590.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Vivian Lopez-BlancoCFOSell9,350$71.22$665,907.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2016Md Pascal J GoldschmidtDirectorSell3,100$65.00$201,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Paul G GabosDirectorSell10,668$67.15$716,356.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2015Md Pascal J. GoldschmidtDirectorSell5,250$70.99$372,697.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2015Cesar L. AlvarezDirectorSell10,668$81.00$864,108.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2015Roger Md MedelCEOSell100,000$80.27$8,027,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2015Karl B WagnerInsiderSell37,820$70.28$2,657,989.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2015Joseph M CalabroCOOSell108,071$70.51$7,620,086.21View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2015Md Pascal J GoldschmidtDirectorSell8,500$71.25$605,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2015Roger Md MedelCEOSell100,000$71.61$7,161,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2015Md Carlo A WaldemarDirectorSell10,668$71.50$762,762.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2015Dominic J AndreanoSVPSell3,200$70.75$226,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2015Vivian Lopez-BlancoCFOSell8,250$69.95$577,087.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Paul G GabosDirectorSell17,584$68.07$1,196,942.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/30/2015William C HawkCOOSell3,598$68.50$246,463.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2014Roger Md MedelCEOSell51,290$62.59$3,210,241.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014Roger Md MedelCEOSell63,440$62.55$3,968,172.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2014Roger Md MedelCEOSell128,833$62.60$8,064,945.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2014Roger Md MedelCEOSell169,845$62.60$10,632,297.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2014Roger Md MedelCEOSell15,052$62.52$941,051.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Roger Md MedelCEOSell10,881$62.52$680,280.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014Roger Md MedelCEOSell61,592$62.58$3,854,427.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2014Karl B WagnerInsiderSell40,000$62.50$2,500,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2014Vivian Lopez-BlancoCFOSell8,800$60.00$528,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2014Karl B WagnerInsiderSell80,000$60.00$4,800,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2014Dominic J AndreanoSVPSell2,252$58.48$131,696.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2014Karl B WagnerInsiderSell44,596$58.53$2,610,203.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014William C HawkCOOSell6,911$57.66$398,488.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014David A ClarkCOOSell16,230$57.00$925,110.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014Michael D StanleyInsiderSell18,006$57.00$1,026,342.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2014Karl WagnerInsiderSell79,524$57.09$4,540,025.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2014Md Pascal GoldschmidtDirectorSell30,000$57.11$1,713,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2014Joseph CalabroCOOSell137,500$57.06$7,845,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Dominic AndreanoSVPSell3,000$61.00$183,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2014Joseph CalabroCOOSell150,000$55.55$8,332,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2014Md Carlo WaldemarDirectorSell10,668$55.40$591,007.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2013Enrique SosaDirectorSell5,334$107.00$570,738.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2013Karl WagnerInsiderSell1,800$107.60$193,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2013William C HawkCOOSell3,162$100.62$318,160.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2013Dominic J AndreanoSVPSell3,718$99.63$370,424.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2013Karl WagnerInsiderSell25,000$98.01$2,450,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Joseph M CalabroCOOSell36,154$98.57$3,563,699.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013David A ClarkCOOSell8,645$91.01$786,781.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Michael D StanleyInsiderSell8,906$91.01$810,535.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for MEDNAX (NYSE:MD)
DateHeadline
06/28/16 05:00 PMStock Performance in Review: MEDNAX, Inc. (NYSE:MD) - Press Telegraph
06/28/16 05:00 PMSell-Side Analyst Views on : MEDNAX, Inc. (NYSE:MD) - Telanagana Press
06/27/16 05:01 PMMednax, Inc (NYSE:MD) Share Review and Earnings Watch - Engelwood Daily
06/27/16 05:01 PMShares in Decline this Year MEDNAX, Inc. (NYSE:MD) - Press Telegraph
06/27/16 05:01 PMTop Stock Pick for Quarter: MEDNAX, Inc. (NYSE:MD) - Engelwood Daily
06/26/16 04:25 PMHow Many MEDNAX Inc (NYSE:MD)'s Analysts Are Bullish? - Press Telegraph
06/26/16 04:25 PMStock Performance Focus on: MEDNAX, Inc. (NYSE:MD) - Press Telegraph
06/26/16 04:25 PMActive Stock Performance : MEDNAX, Inc. (NYSE:MD) - Press Telegraph
06/25/16 04:44 PMShare Performance Recap: MEDNAX, Inc. (NYSE:MD) - Press Telegraph
06/24/16 05:04 PMTracking Share Activity for: MEDNAX, Inc. (NYSE:MD) - Press Telegraph
06/24/16 05:04 PMMednax, Inc (NYSE:MD) Performance Focus and Earnings Preview - Engelwood Daily
06/21/16 09:34 AMMEDNAX (MD) Acquires New York-Based Anesthesiology Practice
06/20/16 07:27 AMMEDNAX, Inc. breached its 50 day moving average in a Bearish Manner : MD-US : June 20, 2016 -
06/20/16 07:15 AMBRIEF-Mednax says announces acquisition of Anesthesiology practice in NY - * Mednax inc says no additional terms of transaction were disclosed
06/20/16 06:02 AMMEDNAX (MD) Acquires New York-Based Anesthesiology Practice - StreetInsider.com
06/20/16 06:02 AMMednax, Inc (NYSE:MD) Analyst Price Targets For The Coming Week - Fiscal Standard
06/20/16 05:59 AMMEDNAX Announces Acquisition of Anesthesiology Practice in New York - [at noodls] - FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jun. 20, 2016-- MEDNAX, Inc. (NYSE: MD), today announced the acquisition of Westchester Anesthesiologists, PC, a private physician group practice based in White ...
06/16/16 09:24 AMMednax Inc. (MD) is Trading Higher on Unusual Volume for June 14 - Equities.com
06/14/16 09:52 AMMedData to buy PE-backed Cardon Outreach for $400 mln
06/13/16 04:45 PMMednax To Acquire Cardon Outreach In $400 Mln Deal
06/13/16 04:45 PMMEDNAX (MD) to Acquire Cardon Outreach in $400M Deal
06/13/16 01:53 PMMEDNAX, Inc. -- Moody's: MEDNAX's acquisition of Cardon Outreach is credit negative; ratings unaffected -
06/13/16 11:52 AM[$$] Mednax to Buy Cardon Outreach for $400 Million -
06/13/16 09:00 AMTerm Sheet — Monday, June 13 -
06/13/16 08:00 AMMEDNAX Announces Agreement to Acquire Cardon Outreach
06/13/16 07:16 AMBRIEF-Mednax to acquire Cardon Outreach for $400 mln - * Mednax inc says acquisition is expected to be immediately accretive to earnings
06/13/16 06:50 AMMEDNAX Agrees To Buy Cardon Outreach For $400 Million -
06/08/16 07:59 AMMEDNAX (MD) Acquires Minneapolis-Based Anesthesiology Practice - StreetInsider.com
06/07/16 05:18 PMRatings Watch: Mednax, Inc (NYSE:MD) - Investor Newswire
06/07/16 12:19 PMMEDNAX, Inc. – Value Analysis (NYSE:MD) : June 7, 2016 -
06/07/16 06:34 AMBRIEF-Mednax announces acquisition of anesthesiology practice in Minnesota - * These were cash transactions, and they are expected to be immediately accretive to earnings
06/07/16 06:18 AMMEDNAX Announces Acquisition of Anesthesiology Practice in Minnesota - [at noodls] - Acquires First Pediatric Ophthalmology Practice FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jun. 7, 2016-- MEDNAX, Inc. (NYSE:MD), today announced the acquisition of Northwest Anesthesia, PA, a private physician ...
06/06/16 07:28 AMMEDNAX, Inc. breached its 50 day moving average in a Bearish Manner : MD-US : June 6, 2016 -
06/04/16 07:52 AMTwo Healthcare Most Traded Stocks: Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) , Mednax, Inc (NYSE:MD) - Is stories
06/03/16 05:31 PMStock Review and Earnings Check on Mednax, Inc (NYSE:MD) - HNN
06/02/16 05:27 PMStock Action Update: MEDNAX, Inc. (NYSE:MD) - HNN - Stock Action Update: MEDNAX, Inc. (NYSE:MD)HNNShares of MEDNAX, Inc. (NYSE:MD) are trading -5.12% year-to-date. Over the previous month, shares have changed -3.01%. A broader check sees the company's quarterly performance at 0.98%. For the past year, share performance sits at -3.52%. It may be ...and more »
06/02/16 07:59 AMMEDNAX, Inc. (NYSE:MD) To Report June 2016 Results - iStreetWire - MEDNAX, Inc. (NYSE:MD) To Report June 2016 ResultsiStreetWireMEDNAX, Inc. (MD) added 0.54% to reach at the floor price of $68.45 as the company is set to share its next quarterly earnings on July 26, 2016. MD stock trades between $68.06 and $68.69 before the earnings release. Let's take a closer look at the June ...and more »
06/01/16 07:57 AMPalisade Capital Management LLC Increased Mednax INC (NYSE:MD) by $3.90 Million as Shares Declined - CCH Daily News - Palisade Capital Management LLC Increased Mednax INC (NYSE:MD) by $3.90 Million as Shares DeclinedCCH Daily NewsPalisade Capital Management Llc increased its stake in Mednax Inc (NYSE:MD) by 11.89% based on its latest 2016Q1 regulatory filing with the SEC. Palisade Capital Management Llc bought 60,932 shares as the company's stock declined 9.05% while stock ...and more »
06/01/16 06:03 AMMEDNAX to Present at Upcoming Investor Conferences - [at noodls] - FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jun. 1, 2016-- MEDNAX, Inc. (NYSE:MD), today announced that it is scheduled to make presentations at two upcoming investor conferences. The company will present ...
05/31/16 05:19 PMStock Performance Check on : MEDNAX, Inc. (NYSE:MD) - HNN - Stock Performance Check on : MEDNAX, Inc. (NYSE:MD)HNNTracking share activity in recent trading action, shares of MEDNAX, Inc. have been recorded 11.47% away from the 52 week low. Company shares have been recently seen -20.50% off of the 52 week high. The stock has been trading at 10.62% separated ...and more »
05/30/16 09:05 PMStock Rating Review for Mednax, Inc (NYSE:MD) - HNN - Stock Rating Review for Mednax, Inc (NYSE:MD)HNNCovering equity analysts presently have a consensus stock rating of 1.77 on shares of Mednax, Inc (NYSE:MD). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research. This consensus rating is compiled by ...and more »
05/30/16 09:05 PMStock Rating Review for Mednax, Inc (NYSE:MD) - HNN - Stock Rating Review for Mednax, Inc (NYSE:MD)HNNCovering equity analysts presently have a consensus stock rating of 1.77 on shares of Mednax, Inc (NYSE:MD). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research. This consensus rating is compiled by ...and more »
05/30/16 09:05 PMStock Paining Investors: MEDNAX, Inc. (NYSE:MD) - HNN - Stock Paining Investors: MEDNAX, Inc. (NYSE:MD)HNNMEDNAX, Inc. (NYSE:MD)'s P/E is 18.96. P/E ratio indicates that a stock's price might be too high or too low when compared to its earnings. There are some investors who might think that a company with a high P/E is overpriced, though sometimes when a ...and more »
05/30/16 09:05 PMStock Paining Investors: MEDNAX, Inc. (NYSE:MD) - HNN - Stock Paining Investors: MEDNAX, Inc. (NYSE:MD)HNNMEDNAX, Inc. (NYSE:MD)'s P/E is 18.96. P/E ratio indicates that a stock's price might be too high or too low when compared to its earnings. There are some investors who might think that a company with a high P/E is overpriced, though sometimes when a ...and more »
05/30/16 09:05 PMMednax, Inc (NYSE:MD) Broker Price Targets For The Coming Week - Share Trading News - Mednax, Inc (NYSE:MD) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Mednax, Inc (NYSE:MD). The latest reports which are currently in issue on Monday 30th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts ...and more »
05/30/16 09:05 PMMednax, Inc (NYSE:MD) Broker Price Targets For The Coming Week - Share Trading News - Mednax, Inc (NYSE:MD) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Mednax, Inc (NYSE:MD). The latest reports which are currently in issue on Monday 30th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts ...and more »
05/29/16 01:22 PMPerformance at a Glance on MEDNAX, Inc. (NYSE:MD) - HNN - Performance at a Glance on MEDNAX, Inc. (NYSE:MD)HNNWhen speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how MEDNAX, Inc. (NYSE:MD)'s stock has performed at various points in its past. Currently, the stock ...and more »
05/28/16 12:55 PMMEDNAX : Shady Grove Medical Center Neonatology Team Wins Quality and Patient Safety Excellence Award - MEDNAX, the national health solutions partner specializing in ... Shady Grove Medical Center in Rockville, MD, was awarded the AHC Quality and Patient Safety Excellence Award. The award was given for the team’s quality improvement project that reduced ...
05/27/16 01:56 PMEarnings Review and Stock Rundown for Mednax, Inc (NYSE:MD) - Wall Street Hints and News - Earnings Review and Stock Rundown for Mednax, Inc (NYSE:MD)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Mednax, Inc (NYSE:MD) to post quarterly ...and more »
05/27/16 01:56 PMMednax, Inc (NYSE:MD) Updated Broker Price Targets - Share Trading News - Mednax, Inc (NYSE:MD) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Mednax, Inc (NYSE:MD). The latest reports which are currently in issue on Friday 27th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts ...and more »
About MEDNAX

MEDNAX logoMEDNAX, Inc. (MEDNAX) is a provider of physician services, including newborn, maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units, primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals, 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists and pediatric surgeons.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Specialized Health Services
  • Sub-Industry: Health Care Services
  • Exchange: NYSE
  • Symbol: MD
  • CUSIP: 58502B10
Key Metrics:
  • Previous Close: $69.53
  • 50 Day Moving Average: $68.92
  • 200 Day Moving Average: $67.96
  • P/E Ratio: 19.88
  • P/E Growth: 1.15
  • Market Cap: $6.59B
  • Current Quarter EPS Consensus Estimate: $4.26 EPS
Additional Links:
MEDNAX (NYSE:MD) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha